Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

OncologyNews archives 2018

The ESMO OncologyPRO news, provided in partnership with medwireNews.

Anticancer Agents;  Clinical Research;  Cancers in Adolescents and Young Adults (AYA);  Personalised/Precision Medicine;  Basic Scientific Principles;  Basic Principles in the Management and Treatment (of cancer);  Therapy;  Biological Therapy

Larotrectinib Benefits Found Across TRK Fusion-Positive Tumour Populations

By Lynda Williams, Senior medwireNews Reporter
Anticancer Agents;  Clinical Research;  Leukaemia;  Lymphomas;  Personalised/Precision Medicine;  Basic Scientific Principles;  Basic Principles in the Management and Treatment (of cancer);  Therapy;  Biological Therapy

Ibrutinib, Umbralisib Results Published For CLL Patients

By Lynda Williams, Senior medwireNews Reporter

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings